1. Home
  2. KVHI vs FATE Comparison

KVHI vs FATE Comparison

Compare KVHI & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KVH Industries Inc.

KVHI

KVH Industries Inc.

N/A

Current Price

$7.59

Market Cap

136.4M

Sector

Technology

ML Signal

N/A

Logo Fate Therapeutics Inc.

FATE

Fate Therapeutics Inc.

N/A

Current Price

$2.39

Market Cap

125.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KVHI
FATE
Founded
1978
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
136.4M
125.6M
IPO Year
1996
2013

Fundamental Metrics

Financial Performance
Metric
KVHI
FATE
Price
$7.59
$2.39
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
$4.10
AVG Volume (30 Days)
162.1K
1.8M
Earning Date
05-07-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
33.33
29.88
EPS
0.04
N/A
Revenue
$9,622,000.00
$6,646,000.00
Revenue This Year
$28.90
N/A
Revenue Next Year
$31.85
N/A
P/E Ratio
$188.00
N/A
Revenue Growth
3.82
N/A
52 Week Low
$5.09
$0.93
52 Week High
$13.00
$3.23

Technical Indicators

Market Signals
Indicator
KVHI
FATE
Relative Strength Index (RSI) 39.40 43.54
Support Level $7.32 $2.24
Resistance Level $7.67 $2.88
Average True Range (ATR) 0.32 0.15
MACD -0.00 -0.02
Stochastic Oscillator 35.68 25.81

Price Performance

Historical Comparison
KVHI
FATE

About KVHI KVH Industries Inc.

KVH Industries Inc provides integrated, end-to-end services, software, and hardware that support its customers' need for access to the Internet, VoIP, operations content, and entertainment services. It offers high-speed Internet and Voice over Internet Protocol (VoIP) services via satellite and integrated 5G/LTE cellular communications to mobile users at sea and on land. The company also provides commercially licensed entertainment, including news, sports, music, and movies, to commercial and leisure customers in the maritime, hotel, and retail markets. It operates in several geographic areas, including internationally. Revenues are generated from international locations, mainly consisting of Singapore, Canada, South America, European Union and other European countries, and other regions.

About FATE Fate Therapeutics Inc.

Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.

Share on Social Networks: